Search

Your search keyword '"Bassand Jean-Pierre"' showing total 727 results

Search Constraints

Start Over You searched for: Author "Bassand Jean-Pierre" Remove constraint Author: "Bassand Jean-Pierre"
727 results on '"Bassand Jean-Pierre"'

Search Results

2. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)

3. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

4. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry

8. Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry

9. Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry

10. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry

11. Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry.

12. Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry

13. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

14. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

16. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.

17. Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

21. Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry

25. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

26. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation

27. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan ― Insights From GARFIELD-AF ―

29. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

32. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data

34. Supplement to: Rivaroxaban in patients with a recent acute coronary syndrome.

40. Early versus delayed invasive intervention in acute coronary syndromes

41. Fourth universal definition of myocardial infarction (2018)

42. Comparative effectiveness of oral anticoagulants in everyday practice

43. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

46. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry

47. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction

48. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke

49. Contributors

Catalog

Books, media, physical & digital resources